HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Loris De Cecco Selected Research
Loris De Cecco Research Topics
Disease
53
Neoplasms (Cancer)
11/2022 - 09/2004
21
Breast Neoplasms (Breast Cancer)
01/2022 - 06/2005
11
Ovarian Neoplasms (Ovarian Cancer)
03/2021 - 10/2004
11
Squamous Cell Carcinoma of Head and Neck
01/2021 - 04/2015
5
Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 04/2015
5
Ovarian Epithelial Carcinoma
01/2022 - 07/2015
5
Carcinoma (Carcinomatosis)
01/2020 - 03/2010
5
Carcinogenesis
12/2019 - 10/2004
3
Melanoma (Melanoma, Malignant)
11/2022 - 06/2004
3
Disease Progression
11/2022 - 12/2017
3
Glioma (Gliomas)
06/2022 - 06/2014
3
Hypoxia (Hypoxemia)
01/2022 - 04/2015
3
Squamous Cell Neoplasms (Squamous Cell Cancer)
12/2019 - 01/2016
2
Infections
03/2021 - 01/2021
2
Neoplasm Metastasis (Metastasis)
04/2020 - 01/2017
2
Adenocarcinoma of Lung
10/2019 - 06/2009
2
Sarcoma (Soft Tissue Sarcoma)
11/2018 - 01/2017
2
Colonic Neoplasms (Colon Cancer)
01/2016 - 01/2012
2
Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 01/2013
1
Circulating Neoplastic Cells
01/2022
1
Triple Negative Breast Neoplasms
01/2022
1
Breast Diseases (Breast Disease)
08/2021
1
Rheumatoid Arthritis
06/2021
1
Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2021
1
Pathologic Complete Response
01/2021
1
Progressive Multifocal Leukoencephalopathy
01/2021
1
Renal Cell Carcinoma (Grawitz Tumor)
01/2021
1
Virus Diseases (Viral Diseases)
01/2021
1
Diarrhea
01/2021
1
Papillary Thyroid Cancer
11/2020
1
Lymphatic Metastasis
11/2020
1
Multiple Myeloma
10/2020
Drug/Important Bio-Agent (IBA)
25
MicroRNAs (MicroRNA)
IBA
01/2022 - 03/2010
10
Biomarkers (Surrogate Marker)
IBA
04/2021 - 11/2009
9
Biological Products
IBA
06/2022 - 10/2004
8
Estrogen Receptors
IBA
01/2020 - 06/2005
7
Proteins (Proteins, Gene)
FDA Link
01/2020 - 01/2014
5
RNA (Ribonucleic Acid)
IBA
01/2022 - 06/2004
5
Cetuximab (Erbitux)
FDA Link
12/2019 - 01/2016
5
Platinum
IBA
12/2019 - 01/2013
4
Trastuzumab (Herceptin)
FDA Link
01/2022 - 09/2015
4
Pharmaceutical Preparations
IBA
01/2021 - 01/2016
4
Complementary DNA (cDNA)
IBA
06/2008 - 06/2004
3
Phenobarbital (Luminal)
FDA Link
01/2020 - 07/2015
3
Urethane (Ethyl Carbamate)
IBA
11/2017 - 04/2014
3
Messenger RNA (mRNA)
IBA
01/2017 - 01/2015
3
Cisplatin (Platino)
FDA Link
Generic
07/2015 - 10/2011
3
DNA (Deoxyribonucleic Acid)
IBA
01/2013 - 10/2011
3
CPG-oligonucleotide
IBA
01/2013 - 10/2011
2
Vemurafenib
IBA
11/2022 - 01/2016
2
dipinacoline glutamate
IBA
06/2022 - 06/2014
2
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2020 - 07/2015
2
Long Noncoding RNA
IBA
01/2020 - 01/2017
2
Vinorelbine (Navelbine)
FDA Link
Generic
07/2018 - 06/2014
2
nimotuzumab
IBA
07/2018 - 06/2014
2
Type 4 Fibroblast Growth Factor Receptor
IBA
06/2009 - 10/2004
2
Estrogen Receptor Modulators (Antiestrogen)
IBA
10/2008 - 06/2005
1
Drug Combinations
IBA
11/2022
1
Mechanistic Target of Rapamycin Complex 1
IBA
11/2022
1
dabrafenib
IBA
11/2022
1
trametinib
IBA
11/2022
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2022
1
MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)
IBA
11/2022
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2022
1
Complement System Proteins (Complement)
IBA
12/2021
1
pristane (pristan)
IBA
06/2021
1
Viral RNA
IBA
03/2021
1
COVID-19 Vaccines
IBA
03/2021
1
Methionine (L-Methionine)
FDA Link
01/2021
1
Choline Kinase
IBA
01/2021
1
Choline (Choline Chloride)
IBA
01/2021
1
Ligands
IBA
01/2021
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2021
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
01/2021
1
Vasopressins (Vasopressin)
IBA
01/2021
1
Anti-Bacterial Agents (Antibiotics)
IBA
01/2021
1
Interferons
IBA
01/2021
1
Nivolumab
IBA
01/2021
1
Immune Checkpoint Inhibitors
IBA
01/2021
1
Granzymes (Granzyme)
IBA
01/2021
1
Alkylating Agents
IBA
10/2020
1
Proteasome Inhibitors
IBA
10/2020
1
Immunomodulating Agents
IBA
10/2020
1
Tumor Biomarkers (Tumor Markers)
IBA
04/2020
1
Untranslated RNA (Noncoding RNA)
IBA
01/2020
1
Formaldehyde (Formol)
FDA Link
01/2020
1
Paraffin
IBA
01/2020
1
Piwi-Interacting RNA
IBA
01/2020
1
matrigel
IBA
01/2020
1
Transforming Growth Factor beta (TGF-beta)
IBA
01/2020
1
Smoke
IBA
10/2019
Therapy/Procedure
19
Therapeutics
11/2022 - 10/2008
10
Drug Therapy (Chemotherapy)
10/2020 - 10/2011
4
Neoadjuvant Therapy
01/2022 - 01/2021
2
Aftercare (After-Treatment)
01/2022 - 01/2021
2
Immunotherapy
01/2021 - 01/2017
2
Re-Irradiation
07/2018 - 06/2014
1
Salvage Therapy
01/2022
1
Injections
01/2021
1
Immunomodulation
01/2021